Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryan Williams

Showing results (201-210 of 417) with videos related to

Pageof 42
Sort By:
Diabetes Care|October 29, 2017
Changes in Albuminuria and the Risk of Major Clinical Outcomes in Diabetes: Results From ADVANCE-ONMin Jun, Toshiaki Ohkuma, Sophia Zoungas, et al.
Journal of Hypertension|June 12, 2018
Do patients actually do what we ask: patient fidelity and persistence to the Targets and Self-Management for the Control of Blood Pressure in Stroke and at Risk Groups blood pressure self-management interventionClaire L Schwartz, Ashkon Seyed-Safi, Sayeed Haque, et al.
Hypertension (Dallas, Tex. : 1979)|June 15, 2007
Central blood pressure measurements and antihypertensive therapy: a consensus documentEnrico Agabiti-Rosei, Giuseppe Mancia, Michael F O'Rourke, et al.
BMJ Open|August 9, 2015
Prevention And Treatment of Hypertension With Algorithm-based therapy (PATHWAY) number 2: protocol for a randomised crossover trial to determine optimal treatment for drug-resistant hypertensionBryan Williams, Thomas M MacDonald, Mark Caulfield, et al.
Diabetes Care|August 9, 2015
Relationship between levels of advanced glycation end products and their soluble receptor and adverse outcomes in adults with type 2 diabetesMerlin C Thomas, Mark Woodward, Bruce Neal, et al.
Hypertension (Dallas, Tex. : 1979)|October 29, 2025
Renal Denervation in Patients With Moderate to Severe Chronic Kidney DiseaseMarkus P Schlaich, Felix Mahfoud, Michael Böhm, et al.
Journal of the American Heart Association|January 15, 2013
Resting heart rate and the risk of microvascular complications in patients with type 2 diabetes mellitusGraham S Hillis, Jun Hata, Mark Woodward, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 27, 2022
Short-Term Changes in Serum Potassium and the Risk of Subsequent Vascular Events and Mortality: Results from a Randomized Controlled Trial of ACE InhibitorsToshiaki Ohkuma, Katie Harris, Mark Cooper, et al.
Lancet (London, England)|August 27, 2011
Cost-effectiveness of options for the diagnosis of high blood pressure in primary care: a modelling studyKate Lovibond, Sue Jowett, Pelham Barton, et al.
Eclinicalmedicine|November 1, 2021
Seven days treatment with the angiotensin II type 2 receptor agonist C21 in hospitalized COVID-19 patients; a placebo-controlled randomised multi-centre double-blind phase 2 trialGöran Tornling, Rohit Batta, Joanna C Porter, et al.
Pageof 42

Showing results (201-210 of 417) with videos related to

Sort By:
Pageof 42
Diabetes Care|October 29, 2017
Changes in Albuminuria and the Risk of Major Clinical Outcomes in Diabetes: Results From ADVANCE-ONMin Jun, Toshiaki Ohkuma, Sophia Zoungas, et al.
Journal of Hypertension|June 12, 2018
Do patients actually do what we ask: patient fidelity and persistence to the Targets and Self-Management for the Control of Blood Pressure in Stroke and at Risk Groups blood pressure self-management interventionClaire L Schwartz, Ashkon Seyed-Safi, Sayeed Haque, et al.
Hypertension (Dallas, Tex. : 1979)|June 15, 2007
Central blood pressure measurements and antihypertensive therapy: a consensus documentEnrico Agabiti-Rosei, Giuseppe Mancia, Michael F O'Rourke, et al.
BMJ Open|August 9, 2015
Prevention And Treatment of Hypertension With Algorithm-based therapy (PATHWAY) number 2: protocol for a randomised crossover trial to determine optimal treatment for drug-resistant hypertensionBryan Williams, Thomas M MacDonald, Mark Caulfield, et al.
Diabetes Care|August 9, 2015
Relationship between levels of advanced glycation end products and their soluble receptor and adverse outcomes in adults with type 2 diabetesMerlin C Thomas, Mark Woodward, Bruce Neal, et al.
Hypertension (Dallas, Tex. : 1979)|October 29, 2025
Renal Denervation in Patients With Moderate to Severe Chronic Kidney DiseaseMarkus P Schlaich, Felix Mahfoud, Michael Böhm, et al.
Journal of the American Heart Association|January 15, 2013
Resting heart rate and the risk of microvascular complications in patients with type 2 diabetes mellitusGraham S Hillis, Jun Hata, Mark Woodward, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 27, 2022
Short-Term Changes in Serum Potassium and the Risk of Subsequent Vascular Events and Mortality: Results from a Randomized Controlled Trial of ACE InhibitorsToshiaki Ohkuma, Katie Harris, Mark Cooper, et al.
Lancet (London, England)|August 27, 2011
Cost-effectiveness of options for the diagnosis of high blood pressure in primary care: a modelling studyKate Lovibond, Sue Jowett, Pelham Barton, et al.
Eclinicalmedicine|November 1, 2021
Seven days treatment with the angiotensin II type 2 receptor agonist C21 in hospitalized COVID-19 patients; a placebo-controlled randomised multi-centre double-blind phase 2 trialGöran Tornling, Rohit Batta, Joanna C Porter, et al.
Pageof 42